MolTag

"Ion channels and transporters as molecular drug targets" (MolTag) is a PhD/doctoral program in pharmaceutical sciences established at the University of Vienna, the Medical University of Vienna, the Vienna University of Technology and the Institute of Science and Technology Austria at Klosterneuburg. The graduate program is financed by a research grant of the Austrian Science Fund (FWF) since 2011. MolTag offers a broad three-year PhD education in pharmaceutical sciences including specialized field courses such as molecular pharmacology, pharmacoinformatics, structure-function analysis of target molecules, biophysics, imaging and advanced synthetic chemistry. Applicants at MolTag have completed a diploma study in medicine or a high quality master program in natural sciences, such as pharmacy, biology, molecular biology or chemistry. MolTag provides comprehensive training in relevant research areas of pharmaceutical research, with focus on drug discovery and drug development. MolTag will provide PhD students with contacts to national and international research labs, including the pharmaceutical industry. We aim to create an atmosphere of collaborative and interdisciplinary research.

Info!

Application period is closed; applicants who did not get invited for an interview will be notified. Final decisions will be taken after all invited applicants have been interviewed.

Latest News

18.06.2019
 

On June 7th, Martin Berger, PhD Student in the Maulide Group successfully defended his thesis at the Faculty of Chemistry at University of Vienna.

17.05.2019
 

The University of Vienna reports a paper which is firstauthored by MolTag student Xingyu Chen (Weinzinger Group): "Computational identification of...

09.05.2019
 

Due to her outstanding scientific achievements, Leticia González has been announced as new corresponding member of the Austrian Academy of Sciences....

Latest Announcements

09.05.2019
 

"Complex natural products as tool to explore cancer progression and cell motility" by Cristina Nevado, Friday June 7th, 15:15; for details see...